home about governance contact links
Recently completed courses:

  Centre for TB Research Innovation Courses:
  Recently completed courses:
    CRRS Course
  Lung Clinical Research Unit Courses:
  Recently completed courses:
    TCC Course
    Smoking Cessation Symposium
    Physiology Symposium
    Sleep Course
  Lung Clinical Research Unit upcoming meetings:
    Academic Respiratory Society & UCT Lung Institute
  Lung Infection &
Immunity Unit:
  Recently completed courses:
    MDR / XDR-TB
    XDR-TB course
    GCP Training the
trainers workshops
Pulmonology Course
  Lung Infection and
Immunity Unit Studies:
    Collabrative Studies
and funding

Lung Infection and Immunity Unit

TB-NEAT: TB diagnostics in low-resource settings
Unit Head: Keertan Dheda, MBBcH (Wits), FCP (SA), FCCP, PhD (Lond), FRCP (Lond)
email: keertan.dheda@uct.ac.za

Keertan Dheda is Professor of Respiratory Medicine and Head of the Lung Infection and Immunity Unit embedded within at the UCT Lung Institute and the Department of Medicine, University of Cape Town, and also an associate member at the IIDMM, UCT. He is an attending Consultant General Physician and Pulmonologist at Groote Schuur Hospital and UCT Private Academic Hospital in Observatory in Cape Town. He also occupies a South African Department of Science and Technology - National Research Foundation Chair in Lung Infection and Immunity and is a Fellow of the University of Cape Town. He completed his PhD in Mycobacterial Immunity at UCL where he holds a Faculty and Honorary Consultant position in the Department of Infection. He was the recipient of the 2010 International Union against Tuberculosis and Lung Disease Scientific Award in 2010 for his outstanding contribution to the field of TB and lung disease. The Lung Infection and Immunity Unit is an WHO-associated ANDI Center for Diagnostic Excellence. The groups main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, development and validation of rapid and field-friendly diagnostics for pulmonary infections, and outcome and intervention studies of drug-resistant tuberculosis.

This work, including several international multi centric studies (TB-NEAT, TBsusgent, TESA HIV-longitudinal), is funded by the MRC, NRF, EU FP7, EDCTP, NIH, Fogarty, Discovery Foundation, Polio Research Foundation, GSK (through the SA Thoracic Society), Astra Zeneca (through the SA Thoracic Society), and other charities.

Active collaboration have been established with the following groups:

McGill University, Canada - (M Pai, D Menzies);
UCL, London - (G Rook and M Noursadeghi);
NYU; USA - (Bill Rom and Doris Tse);
University of Sassari, Italy - (Leonardo Sechi);
Tuberculosis Centre, Barstel (Christoph Lange);
University Munich, Germany - (Mike Hoelscher);
Lusaka, Zambia - (Peter Mwaba);
UKZN, Durban, South Africa - (Thumbi Ndungu and Vinod Patel);

UMDNJ, New Jersey, USA - (Stephan Schwander);
University of Stellenbosch, SA - (Gerhardt Walzl, Rob Warren and
Tommie Victor);
AIIMS, India - (Suren Sharma);
SVIMS, India - (Mohan Alladi);
Centre for Proteomics, UCT - (Jonathan Blackburn);
Botswana Harvard AIDS Institute Partnership for HIV Research and Education - (Rosemary Musonda);
Biomedical Research & Training Institute, Harare - (Peter Mason);

University of Zimbabwe College of Health Sciences - (Lynn Zinjenah);
Research Support centre, College of Medicine, University of Malawi - (Exnevia Gomo);
Direcção De Saűde De Cidade De Maputo - (Zulmira Silva);

Liverpool School of Tropical Medicine - (Professor Stephen Gordon and Professor Stephen Ward);
Medical Research Council, Durban (Alex Pym and Thuli Mthiyane);
K-Rith, Durban, South Africa - (Victoria Kasparowitz);
Public Health Research Institute (UMDNJ) - (Gilla Kaplan)
University of Florida (Kevin Fennelley);
Bram van Ginneken, Markus Maeurer - Karolinska Institute

The Lung Infection and Immunity Unit actively pursues equitable partnerships with collaborators. We subscribe to the principles of gender equality and transformation.